High-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imaging

[1]  K. Kinowaki,et al.  Clinical prediction model based on 18F-FDG PET/CT plus contrast-enhanced MRI for axillary lymph node macrometastasis , 2022, Frontiers in Oncology.

[2]  M. Kerin,et al.  Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis , 2021, The Breast : Official Journal of the European Society of Mastology.

[3]  L. Middleton,et al.  Axillary Nodal Metastases in Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma: Comparison of Node Detection and Morphology by Ultrasound. , 2021, AJR. American journal of roentgenology.

[4]  L. Valentin,et al.  Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group , 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  S. Lakhani,et al.  Invasive lobular carcinoma of the breast: the increasing importance of this special subtype , 2021, Breast Cancer Research.

[7]  W. Moon,et al.  Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI , 2021, Breast Cancer Research and Treatment.

[8]  M. O’Neil,et al.  Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging? , 2021, Breast Cancer Research and Treatment.

[9]  Hee Jung Shin,et al.  Diagnostic performance of standard breast MR imaging compared to dedicated axillary MR imaging in the evaluation of axillary lymph node , 2020, BMC Medical Imaging.

[10]  S. Engelen,et al.  Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer , 2020, European Radiology.

[11]  K. Pinker,et al.  Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools , 2019, The oncologist.

[12]  K. Pinker,et al.  Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools , 2019, The oncologist.

[13]  Abhishek Gupta,et al.  Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma , 2019, Annals of Surgical Oncology.

[14]  S. Cho,et al.  Preoperative axillary nodal staging with ultrasound and magnetic resonance imaging: predictive values of quantitative and semantic features. , 2018, The British journal of radiology.

[15]  J. Litherland,et al.  Population‐based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node‐positive invasive lobular carcinoma of the breast , 2018, The British journal of surgery.

[16]  W. Woodward,et al.  A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer , 2018, Advances in radiation oncology.

[17]  J. Abraham,et al.  Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated? , 2018, American journal of surgery.

[18]  A. Giuliano,et al.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial , 2017, JAMA.

[19]  R. Beets-Tan,et al.  Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients. , 2016, European journal of radiology.

[20]  Brittany Z Dashevsky,et al.  Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma , 2015, The Journal of Nuclear Medicine.

[21]  V. Tjan-Heijnen,et al.  Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer , 2015, Annals of Surgical Oncology.

[22]  Y. Lim,et al.  The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  Janice S Sung,et al.  Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes. , 2014, AJR. American journal of roentgenology.

[24]  S. Barni,et al.  Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer , 2013, Breast Cancer Research and Treatment.

[25]  S. Mclaughlin,et al.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. , 2013, JAMA.

[26]  M. Silverstein,et al.  Accuracy of Predicting Axillary Lymph Node Positivity by Physical Examination, Mammography, Ultrasonography, and Magnetic Resonance Imaging , 2012, Annals of Surgical Oncology.

[27]  I. Ellis,et al.  Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast , 2011, Journal of Clinical Pathology.

[28]  W. Kaiser,et al.  Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study. , 2011, AJR. American journal of roentgenology.

[29]  S. Hochwald,et al.  Magnetic resonance imaging for axillary staging in patients with breast cancer , 2009, Journal of magnetic resonance imaging : JMRI.

[30]  I. Ellis,et al.  Three-dimensional reconstruction of sentinel lymph nodes with metastatic breast cancer indicates three distinct patterns of tumour growth , 2009, Journal of Clinical Pathology.

[31]  L. Bassett,et al.  Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[32]  Ritse M. Mann,et al.  MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature , 2007, Breast Cancer Research and Treatment.

[33]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[34]  R. Rouzier,et al.  The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. , 2004, European journal of cancer.

[35]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[36]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .